Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas
- 31 July 2004
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 41 (1) , 112-118
- https://doi.org/10.1016/j.jhep.2004.03.018
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinomaHepatology, 2002
- Immunohistochemical Detection of Somatostatin Receptors in Human Ovarian TumorsGynecologic Oncology, 2002
- Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodiesGut, 2002
- Systemic Treatment of Hepatocellular CarcinomaDigestive Diseases, 2001
- Somatostatin Receptor Subtypes 2 and 5 Differentially Affect Proliferation in Vitro of the Human Medullary Thyroid Carcinoma Cell Line TTJournal of Clinical Endocrinology & Metabolism, 2001
- Regulatory peptide receptors in human hepatocellular carcinomasGut, 1999
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- Treatment of hepatocellular carcinoma with octreotide: a randomised controlled studyGut, 1998
- OctreotideNew England Journal of Medicine, 1996
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973